can tirzepatide cause birth defects What to know about UK warning on weight loss drugs' effect on control ✨Contraception needs to be considered

5d and Supplementary Fig

Tirzepatide received UK marketing authorisation in 2023, and NICE Technology Appraisal (TA) 870 supports its use in specific patient populations with type 2 diabetes who have not achieved adequate glycaemic control with other treatments

RESEARCH USE ONLY Not for human or veterinary use

You may experience skin sensitivity, hyperesthesia (touch feels extra intense or uncomfortable), skin pain, burning skin sensations, or paresthesia (pins and needles feeling)

A 20-year real-world ramelteon safety study revealed a broad spectrum of AEsincluding unique sensory experiences (e.g., hangover, derealisation, feeling drunk), reproductive system effects (e.g., decreased libido, priapism), hallucination-related AEs (e.g., visual hallucinations), and rare but clinically significant reactions.23 Thats a lot of potential adverse effects

Predictors of Weight Regain: A Clinical Framework Research identifies several factors that influence how much weight returns after tirzepatide discontinuation